Insulin secretion defects of human type 2 diabetic islets are corrected in vitro by a new reactive oxygen species scavenger.

Oxidative stress is a putative mechanism leading to beta-cell damage in type 2 diabetes. We studied isolated human pancreatic islets from type 2 diabetic and non-diabetic subjects, matched for age and body mass index. Evidence of increased oxidative stress in diabetic islets was demonstrated by measuring nitrotyrosine concentration and by electron paramagnetic resonance. This was accompanied by reduced glucose-stimulated insulin secretion, as compared to non-diabetic islets (Stimulation Index, SI: 0.9 +/- 0.2 vs. 2.0 +/- 0.4, P<0.01), and by altered expression of insulin (approximately -60%), catalase (approximately +90%) and glutathione peroxidase (approximately +140%). When type 2 diabetic islets were pre-exposed for 24 h to the new antioxidant bis(1-hydroxy-2,2,6,6-tetramethyl-4-piperidinyl)decandioate di-hydrochloride, nitrotyrosine levels, glucose-stimulated insulin secretion (SI: 1.6+/-0.5) and gene expressions improved/normalized. These results support the concept that oxidative stress may play a role in type 2 diabetes beta-cell dysfunction; furthermore, it is proposed that therapy with antioxidants could be an interesting adjunctive pharmacological approach to the treatment of type 2 diabetes.

[1]  C. Bogardus,et al.  The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. , 1999, The Journal of clinical investigation.

[2]  U. Boggi,et al.  Gliclazide protects human islet beta‐cells from apoptosis induced by intermittent high glucose , 2007, Diabetes/metabolism research and reviews.

[3]  Nils Welsh,et al.  Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. , 2005, Diabetes.

[4]  R. Robertson,et al.  Diabetes, glucose toxicity, and oxidative stress: A case of double jeopardy for the pancreatic islet beta cell. , 2006, Free radical biology & medicine.

[5]  U. Boggi,et al.  Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients , 2005, Diabetologia.

[6]  E. Opara.  Role of Oxidative Stress in the Etiology of Type 2 Diabetes and the Effect of Antioxidant Supplementation on Glycemic Control , 2004, Journal of Investigative Medicine.

[7]  J. Sturis,et al.  Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance. , 1996, The New England journal of medicine.

[8]  A. Ceriello.  Nitrotyrosine: new findings as a marker of postprandial oxidative stress. , 2002, International journal of clinical practice. Supplement.

[9]  R. Robertson,et al.  A role for glutathione peroxidase in protecting pancreatic β cells against oxidative stress in a model of glucose toxicity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[10]  P. B. D. de Andrade,et al.  Mitochondrial damages and the regulation of insulin secretion. , 2006, Biochemical Society transactions.

[11]  L. Valgimigli,et al.  Quantitative evaluation of oxidative stress status on peripheral blood in β‐thalassaemic patients by means of electron paramagnetic resonance spectroscopy , 2005, British journal of haematology.

[12]  V. Monnier,et al.  Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. , 1997, The Journal of clinical investigation.

[13]  S. Kahn,et al.  The Importance of β-Cell Failure in the Development and Progression of Type 2 Diabetes , 2001 .

[14]  P. Halban,et al.  Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications , 2004, Diabetologia.

[15]  D. Treré,et al.  Oxidative Stress EPR Measurement in Human Liver by Radical-probe Technique. Correlation with Etiology, Histology and Cell Proliferation , 2002, Free radical research.

[16]  Y. Xiangliang,et al.  Puerarin protects rat pancreatic islets from damage by hydrogen peroxide , 2006 .

[17]  O. Schmitz,et al.  High-frequency insulin pulsatility and type 2 diabetes: from physiology and pathophysiology to clinical pharmacology. , 2002, Diabetes & metabolism.

[18]  C. Clark.  The Burden of Chronic Hyperglycemia , 1998, Diabetes Care.

[19]  G. Cantelli-forti,et al.  Captan impairs CYP-catalyzed drug metabolism in the mouse. , 1999, Chemico-biological interactions.

[20]  R. Robertson,et al.  Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. , 2003, Diabetes.

[21]  U. Boggi,et al.  Transcription factors of beta-cell differentiation and maturation in isolated human islets: effects of high glucose, high free fatty acids and type 2 diabetes. , 2006, NMCD. Nutrition Metabolism and Cardiovascular Diseases.

[22]  U. Boggi,et al.  Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. , 2004, The Journal of clinical endocrinology and metabolism.

[23]  Louis H Philipson,et al.  Oxidative Reactive Species in Cell Injury: Mechanisms in Diabetes Mellitus and Therapeutic Approaches , 2005, Annals of the New York Academy of Sciences.

[24]  G. Cantelli-forti,et al.  Paramagnetic resonance in detecting carcinogenic risk from cytochrome P450 overexpression. , 1996, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[25]  J. Shaw,et al.  Global and societal implications of the diabetes epidemic , 2001, Nature.

[26]  U. Boggi,et al.  The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets. , 2006, European journal of endocrinology.

[27]  Xiaoyan Li,et al.  Metallothionein Protects Islets from Hypoxia and Extends Islet Graft Survival by Scavenging Most Kinds of Reactive Oxygen Species* , 2004, Journal of Biological Chemistry.

[28]  George L. King,et al.  Hyperglycemia-induced oxidative stress in diabetic complications , 2004, Histochemistry and Cell Biology.

[29]  A. Ceriello,et al.  Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress , 2001, Diabetologia.

[30]  L. Valgimigli,et al.  Taking EPR "Snapshots" of the Oxidative Stress Status in Human Blood , 2003, Free radical research.

[31]  M. Valgimigli,et al.  Measurement of oxidative stress in human liver by EPR spin-probe technique , 2000, Free radical research.

[32]  U. Boggi,et al.  Functional and molecular defects of pancreatic islets in human type 2 diabetes. , 2005, Diabetes.

[33]  I. Artner,et al.  Regulation of the insulin gene by glucose and fatty acids. , 2006, The Journal of nutrition.

[34]  Christophe Benoist,et al.  β-Cell death during progression to diabetes , 2001, Nature.

[35]  R. Robertson.  Chronic Oxidative Stress as a Central Mechanism for Glucose Toxicity in Pancreatic Islet Beta Cells in Diabetes* , 2004, Journal of Biological Chemistry.

[36]  Robert A. Rizza,et al.  β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes , 2003, Diabetes.